American Century Companies’s Mineralys Therapeutics MLYS Stock Holding History

American Century Companies's MLYS Position: Q2 2026 in Review

American Century Companies increased its Mineralys Therapeutics (MLYS) stake by 17% in Q2 2026, buying an estimated $4.19M and bringing the position to 1,036,767 shares worth $28M. The position accounts for 0.01% of the portfolio, ranked #1119.

American Century Companies first reported a position in MLYS in Q1 2023 and has held it in 14 quarters since. The position peaked at $33.4M in Q3 2025. 194 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

• American Century Companies held 1,036,767 shares of Mineralys Therapeutics worth $28M as of Q2 2026.
• American Century Companies bought 152,660 Mineralys Therapeutics shares in Q2 2026, an estimated $4.19M.
• Mineralys Therapeutics made up 0.01% of American Century Companies's portfolio in Q2 2026, its #1119 holding.
• American Century Companies first reported a position in Mineralys Therapeutics in Q1 2023 and has held it in 14 quarters since.
• American Century Companies's Mineralys Therapeutics position peaked at $33.4M in Q3 2025.
• 194 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.